• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

The Future of Mobility: Wandercraft Raises $75M for Self-Balancing Exoskeletons

by Fred Pennic 06/11/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
The Future of Mobility: Wandercraft Raises $75M for Self-Balancing Exoskeletons

What You Should Know: 

– Wandercraft, the global leader in self-balancing robotic mobility systems secures $75M in funding and financing as part of its Series D round. 

– The round saw major contributions from Renault Group, the PSIM fund managed by Bpifrance on behalf of the French State, Teampact Ventures, and Quadrant Management.

Propelling the Next Phase of Growth

Founded in 2012, Wandercraft is globally recognized for creating the world’s first self-balancing walking exoskeleton, Atalante X, which is used in more than 100 rehabilitation centers across four continents to assist individuals with disabilities in taking more than a million steps each month.

The new funding will be used to propel Wandercraft into its next stage of development, with a focus on three key areas:

  • Bringing Eve, the world’s first self-balancing personal exoskeleton, to market as early as 2026.
  • Expanding clinical adoption of its flagship rehabilitation system, Atalante X.
  • Developing and deploying Calvin-40, its new humanoid robot for industrial applications.

Strategic Parntership with Renault Group

A key component of this funding round is a strategic partnership with Renault Group, which now holds a minority stake in Wandercraft. The collaboration brings Renault Group’s industrial expertise to help scale up the production of Wandercraft’s exoskeletons and industrial robots, laying the groundwork for cost-efficient scaling of both the Eve personal exoskeleton and the broader Calvin humanoid family.

Renault Group is also Wandercraft’s first commercial partner and customer for Calvin-40, the first humanoid robot developed by a European company. Calvin-40’s rapid development—achieved in just 40 days—was made possible by leveraging Wandercraft’s existing robotics platform integrated with NVIDIA Isaac technologies.

Recent Traction/Milestones

Wandercraft’s momentum is built on its dedication to restoring independence through self-balancing, hands-free robotic systems that allow upright movement without crutches or walkers. This technology, powered by AI, has been refined through billions of simulations and tens of millions of real-world steps.

Recent milestones include:

  • Receiving two FDA clearances for the Atalante X rehabilitation exoskeleton for stroke recovery.
  • Deploying Atalante X in more than 100 hospitals and rehabilitation centers globally, including the Kessler Foundation and the Villa Beretta Rehabilitation Research Innovation Institute.
  • Launching the world’s first clinical trial of a self-balancing personal exoskeleton, Eve, designed for use at home and in the community.
  • Enabling 2,500 people with mobility disabilities to take more than 14 million steps.
  • Winning a 2025 SXSW Innovation Award in the Artificial Intelligence category.

“The momentum we’ve achieved over the past few years is extraordinary,” said Matthieu Masselin, CEO and Co-founder of Wandercraft. “We’ve expanded globally, launched pivotal clinical trials, readied the commercialization of Eve, our personal exoskeleton, and entered a landmark partnership with Renault Group. This funding allows us to continue our mission of transforming how people live, move, and work.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |